Literature DB >> 12812887

Detection of human papillomavirus DNA in pterygia from different geographical regions.

F Piras1, P S Moore, J Ugalde, M T Perra, A Scarpa, P Sirigu.   

Abstract

BACKGROUND/AIMS: The aetiology and pathogenesis of pterygia remain unclear and the involvement of human papillomavirus (HPV) is controversial. 41 pterygia from two geographic locations were evaluated for the presence of HPV DNA.
METHODS: 41 pterygium biopsies (17 from Italy and 24 from Ecuador) were analysed using the L1C1 and PU-1ML primer sets by polymerase chain reaction (PCR) and DNA sequence analysis.
RESULTS: 22 of the 41 pterygia (54%) were positive for HPV, including all 17 Italian cases and 5/24 (21%) Ecuadorean cases. DNA sequencing of the 22 positive cases showed that 11 were HPV type 52, four were type 54, five were candHPV90, and two of unknown genotype.
CONCLUSIONS: The major differences in the frequency of HPV in geographically distant populations might suggest a possible explanation for the vast differences in the reported detection rates. Three subtypes of HPV were found in this sample of pterygia. None the less, these results suggest that HPV may have a pathogenic role in pterygium.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12812887      PMCID: PMC1771763          DOI: 10.1136/bjo.87.7.864

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  34 in total

Review 1.  p53 function and dysfunction.

Authors:  B Vogelstein; K W Kinzler
Journal:  Cell       Date:  1992-08-21       Impact factor: 41.582

Review 2.  Papillomavirus and HPV typing.

Authors:  E M de Villiers
Journal:  Clin Dermatol       Date:  1997 Mar-Apr       Impact factor: 3.541

Review 3.  Papillomavirus infections--a major cause of human cancers.

Authors:  H zur Hausen
Journal:  Biochim Biophys Acta       Date:  1996-10-09

4.  Cervical intraepithelial neoplasia, anogenital cancer, and other cancer types in women after hospitalization for condylomata acuminata.

Authors:  S Friis; S K Kjaer; M Frisch; L Mellemkjaer; J H Olsen
Journal:  J Infect Dis       Date:  1997-04       Impact factor: 5.226

Review 5.  P53 expression in altered limbal basal cells of pingueculae, pterygia, and limbal tumors.

Authors:  N Dushku; T W Reid
Journal:  Curr Eye Res       Date:  1997-12       Impact factor: 2.424

6.  Identification of genital human papillomaviruses in cervical biopsy specimens: segregation of specific virus types in specific clinicopathologic lesions.

Authors:  T Matsukura; M Sugase
Journal:  Int J Cancer       Date:  1995-03-29       Impact factor: 7.396

7.  Human papillomavirus in pterygium.

Authors:  S Varinli; I Varinli; M Köksal Erkisi; F Doran
Journal:  Cent Afr J Med       Date:  1994-01

8.  Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia.

Authors:  M H Schiffman; H M Bauer; R N Hoover; A G Glass; D M Cadell; B B Rush; D R Scott; M E Sherman; R J Kurman; S Wacholder
Journal:  J Natl Cancer Inst       Date:  1993-06-16       Impact factor: 13.506

9.  Risk analysis in the development of pterygia.

Authors:  F D Mackenzie; L W Hirst; D Battistutta; A Green
Journal:  Ophthalmology       Date:  1992-07       Impact factor: 12.079

10.  HLA-DR antigen expression in pterygium epithelial cells and lymphocyte subpopulations: an immunohistochemistry study.

Authors:  E Ioachim-Velogianni; E Tsironi; N Agnantis; G Datseris; K Psilas
Journal:  Ger J Ophthalmol       Date:  1995-03
View more
  14 in total

1.  Human papillomavirus and pterygium. Is the virus a risk factor?

Authors:  Nicolai Christian Sjö; Christian von Buchwald; Jan Ulrik Prause; Bodil Norrild; Troels Vinding; Steffen Heegaard
Journal:  Br J Ophthalmol       Date:  2006-12-19       Impact factor: 4.638

2.  Epidermal growth factor receptor signaling is partially responsible for the increased matrix metalloproteinase-1 expression in ocular epithelial cells after UVB radiation.

Authors:  Nick Di Girolamo; Minas Coroneo; Denis Wakefield
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

Review 3.  Association of human papilloma virus with pterygia and ocular-surface squamous neoplasia.

Authors:  N Di Girolamo
Journal:  Eye (Lond)       Date:  2011-12-02       Impact factor: 3.775

4.  Phylogeny and evolution of papillomaviruses based on the E1 and E2 proteins.

Authors:  Ignacio G Bravo; Angel Alonso
Journal:  Virus Genes       Date:  2006-08-22       Impact factor: 2.332

5.  The involvement of adult stem cells originated from bone marrow in the pathogenesis of pterygia.

Authors:  Young Soo Song; Yang Hwan Ryu; Suk Rae Choi; Jae Chan Kim
Journal:  Yonsei Med J       Date:  2005-10-31       Impact factor: 2.759

6.  human adenoviruses role in ophthalmic pterygium formation.

Authors:  Mishar Kelishadi; Mandana Kelishadi; Abdolvahab Moradi; Naeme Javid; Masoud Bazouri; Alijan Tabarraei
Journal:  Jundishapur J Microbiol       Date:  2015-04-18       Impact factor: 0.747

Review 7.  Viral involvement in the pathogenesis and clinical features of ophthalmic pterygium (Review).

Authors:  Aikaterini K Chalkia; Demetrios A Spandidos; Efstathios T Detorakis
Journal:  Int J Mol Med       Date:  2013-07-12       Impact factor: 4.101

8.  Relationship between the expression of cyclooxygenase-2 and survivin in primary pterygium.

Authors:  Cristina Maxia; Maria Teresa Perra; Paolo Demurtas; Luigi Minerba; Daniela Murtas; Franca Piras; Renè Cabrera; Domenico Ribatti; Paola Sirigu
Journal:  Mol Vis       Date:  2009-02-27       Impact factor: 2.367

9.  HPV infection and p53 inactivation in pterygium.

Authors:  Yi-Yu Tsai; Chi-Chung Chang; Chun-Chi Chiang; Kun-Tu Yeh; Pei-Liang Chen; Chi-Huang Chang; Ming-Chih Chou; Huei Lee; Ya-Wen Cheng
Journal:  Mol Vis       Date:  2009-06-01       Impact factor: 2.367

10.  Expression of survivin protein in pterygium and relationship with oxidative DNA damage.

Authors:  C Maxia; M T Perra; P Demurtas; L Minerba; D Murtas; F Piras; A Corbu; D C Gotuzzo; R G Cabrera; D Ribatti; P Sirigu
Journal:  J Cell Mol Med       Date:  2008-02-04       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.